FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/02/081392 [Registered on: 27/02/2025] Trial Registered Prospectively
Last Modified On: 21/02/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Clinical Study on Saraswata Churna In Vak-Graha (Stuttering) In Children. 
Scientific Title of Study   A Randomized Control Clinical Study to Evaluate The Efficacy of Saraswata Churna in Vak-Graha (Stuttering) in Children 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Rohit Kumar 
Designation  PhD scholar 
Affiliation  Institute for Ayurved Studies and Research 
Address  Room no 99 P.G.Department of Kaumarbhritya Institute for Ayurved Studies and Research Umri Road Sector 8 Kurukshetra HARYANA 136118

Kurukshetra
HARYANA
136118
India 
Phone  8699538627  
Fax    
Email  rohit4u88@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Amit Kataria 
Designation  Associate professor PG Dept. of Kaumarbhritya 
Affiliation  Institute for Ayurved Studies and Research 
Address  Room no 99 P.G.Department of Kaumarbhritya Institute for Ayurved Studies and Research Umri Road Sector 8 Kurukshetra HARYANA 136118

Kurukshetra
HARYANA
136118
India 
Phone  9034001230  
Fax    
Email  dramitkataria@rediffmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Rohit Kumar 
Designation  Phd Scholar 
Affiliation  Institute for Ayurved Studies and Resea 
Address  Room no 99 P.G.Department of Kaumarbhritya Institute for Ayurved Studies and Research Umri Road Sector 8 Kurukshetra HARYANA 136118

Kurukshetra
HARYANA
136118
India 
Phone  8699538627  
Fax    
Email  rohit4u88@gmail.com  
 
Source of Monetary or Material Support  
Institute for Ayurved Studies and Research Former Shri Krishna Government Ayurvedic College and Hospital Shri Krishna AYUSH University Umri Road Sector 8 Kurukshetra 136118 India 
 
Primary Sponsor  
Name  Institute for Ayurved Studies and Research 
Address  Institute for Ayurved Studies and Research Former Shri Krishna Government Ayurvedic College and Hospital Shri Krishna AYUSH University Umri Road Sector 8 Kurukshetra 136118 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Rohit Kumar  Institute for Ayurved Studies and Research  PG Department of Kaumarbhritya Institute For Ayurved Studies and Research, Kurukshetra Umri road Sector 8 Thanesar Kurukshetra Haryana
Kurukshetra
HARYANA 
8699538627

rohit4u88@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Shri Krishna AYUSH University IEC  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:F801||Expressive language disorder. Ayurveda Condition: VAK-SANGAH (KEVALAVATA),  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator Arm (Non Ayurveda)-Speech TherapySpeech therapy will be done in patient with stuttering.
2Intervention ArmDrugClassical(1) Medicine Name: Saraswata churna , Reference: Sharangdhar Samhita Madhyama Khanda chapter 6 shlok 1, Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 60 Days, anupAna/sahapAna: Yes(details: -Ghrit), Additional Information: -Dose will be calculated with the help of clarks formula and Speech therapy also done with Saraswata churan
 
Inclusion Criteria  
Age From  4.00 Year(s)
Age To  12.00 Year(s)
Gender  Both 
Details  Children in between the age group of 4- 12 years of either sex irrespective of caste, religion
and socio-economic status.
Any pauses, repetition, prolongation of vowels or words.
Slurring of words and distortion of vowels because of lack of strength and muscular control,
causing dysfluency in speech. 
 
ExclusionCriteria 
Details  Patient suffering from sensory aphasia or dysphasia.
Patient suffering from cleft palate & cleft lip or the conditions where the surgical intervention
is required.
Speech disorders secondary to disorders like cerebral palsy etc.
Speech disorders which are complicated with other systemic disorders.
Patient suffering from Dysphonia & Dysarthria 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
The primary outcome will measure change in the clinical symptoms of Stuttering.  60th day 
 
Secondary Outcome  
Outcome  TimePoints 
Change in score of Stuttering severity instrument-3 to assess the efficacy of selected drug.
Assessment of the safety of the drug by documenting the occurrence of any adverse drug
reactions (ADR)/ adverse events (AE) during the course of the study. 
90th 120th 150th and 180th day 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   15/03/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
A randomized clinical trial has been designed to assess the efficacy of Saraswata churan with speech thearpy in the management of Vak-Graha in children of age group 4 year to 12 year is selected from O.P.D. of Kaumarbhritya Department of Institute for Ayurved Studies and Research
 
Close